GLP-1 Aftercare in Focus

FMCG Gurus - GLP-1 Aftercare in Focus - Trend Digest 2026

As GLP-1 medications move from clinical breakthrough to mainstream reality, the focus is shifting from rapid weight loss to the challenge of long-term maintenance. This digest explores the critical "maintenance gap" that emerges when pharmaceutical intervention ends and independent lifestyle habits must begin. Using our consumer insights, we examine how brands can transition from supporting short-term outcomes to becoming lifelong partners in sustained success. Download your copy to understand how to bridge the gap between clinical treatment and lasting lifestyle support.

Inside this digest:

• Why brands must distinguish between "preventative aftercare" for current users and "recovery aftercare" for those who have finished treatment.
• Insights into why reliance on appetite suppression alone creates a long-term risk for consumers once medication ceases.
• Data exploring global usage rates and the specific emotional anxieties users face regarding weight regain and life after medication.
• Which lifestyle areas, from alcohol consumption to stress management, consumers are proactively adjusting during their journey.
• The hidden impact of treatment on muscle mass and what this means for future nutritional needs and metabolic rates.
• How to move messaging away from restriction and toward empowerment to foster long-term loyalty and independent progress.

How this helps brands:

Brands can learn to segment the support journey by recognizing that current and former users have distinct needs requiring tailored messaging. By prioritizing habit formation over short-term outcomes, companies can address the gap where appetite suppression ends and independent choices begin.